# US 2015/0175975 A1 · Alphavirus Compositions and Methods of Use

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0175975 A1
- Document ID: US20150175975A1
- Status: Published application
- Kind: A1
- Application number: 14/525,820
- Filed: 2014-10-28
- Published: 2015-06-25
- Earliest claimed: 2010-12-22
- Assignees: Board of Regents, The University of Texas System
- Inventors: Farooq Nasar; Jesse Erasmus; Scott C. Weaver
- Web page: https://patentgrep.com/patent/US20150175975A1

## CPC

- C12N 7/00: Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof (preparing medicinal viral antigen or antibody compositions, e.g. virus vaccines, A61K39/00)
- G01N 33/56983: {Viruses}
- A61K 39/12: Viral antigens
- C12N 2770/36121: Viruses as such, e.g. new isolates, mutants or their genomic sequences
- C12N 2770/36134: Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- G01N 2333/181: Alphaviruses or Group A arboviruses, e.g. sindbis, VEE, EEE, WEE or semliki forest virus
- G01N 2469/20: Detection of antibodies in sample from host which are directed against antigens from microorganisms
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

Embodiments are directed compositions related to Eilat virus and uses thereof. Certain aspects are directed to the detection of non-Eilat entities using a chimeric Eilat alphavirus as a capture agent.

## Claims

### Claim 1

A chimeric alphavirus having a genome comprising (a) all or part of a non-structural protein coding segment having at least 95% identity to a non-structural protein coding segment of SEQ ID NO:1 and (b) a structural protein coding segment of chikungunya virus.

### Claim 2 (depends on 1)

The chimeric alphavirus of claim 1, wherein the non-structural protein coding segment of SEQ ID NO:1 encodes nsP1, nsP2, nsP3, and/or nsP4.

### Claim 3 (depends on 1)

The chimeric alphavirus of claim 1, wherein the a non-structural protein coding segment of SEQ ID NO:1 encoding nsP1, nsP2, nsP3, and nsP4.

### Claim 4 (depends on 1)

The chimeric alphavirus of claim 1, wherein the structural protein coding segment of the chikungunya virus encodes C, E1, and/or E2.

### Claim 5 (depends on 1)

The chimeric alphavirus of claim 1, wherein the structural protein coding segment of the chikungunya virus encodes C, E1, and E2.

### Claim 6 (depends on 1)

An immunogenic composition comprising the alphavirus of claim 1.

### Claim 7 (depends on 6)

A method of stimulating an immune response in a subject comprising administering an effective amount of an immunogenic composition of claim 6.

### Claim 8

A diagnostic kit comprising a chimeric Eilat alphavirus comprising a heterologous polypeptide of a non-Eilat alphavirus.

### Claim 9 (depends on 8)

The kit of claim 8, wherein the non-Eilat alphavirus is selected from the group consisting of Ross River (RRV), chikungunya (CHIKV), Sindbis (SINV) Venezuelan equine encephalitis (VEEV), Eastern equine encephalitis (EEEV) and Western equine encephalitis (WEEV) protein.

### Claim 10 (depends on 8)

The kit of claim 8, wherein the non-Eilat alphavirus is chikungunya virus.

### Claim 11 (depends on 8)

The kit of claim 8, wherein the chimeric Eilat alphavirus is coupled to a substrate.

### Claim 12 (depends on 11)

The kit of claim 11, wherein the chimeric Eilat alphavirus is covalently coupled to a substrate.

### Claim 13 (depends on 8)

The kit of claim 8, further comprising a detection reagent.
